CymitQuimica logo

CAS 4497-29-4

:

Methane, oxybis[bromo-

Description:
Methane, oxybis[bromo-] is a chemical compound characterized by the presence of bromine atoms attached to a methane backbone. It is a derivative of methane, where two bromine atoms are substituted for hydrogen atoms, and it contains an ether-like functional group due to the presence of an oxygen atom. This compound is typically a colorless gas or liquid, depending on the temperature and pressure conditions. It is known for its reactivity, particularly in halogenation reactions, and can participate in various chemical processes, including combustion and substitution reactions. The presence of bromine atoms imparts significant reactivity, making it useful in organic synthesis and as a potential intermediate in the production of other chemical compounds. Safety considerations are important when handling this substance, as brominated compounds can be hazardous and may pose environmental risks. Proper storage and handling protocols should be followed to mitigate any potential risks associated with its use.
Formula:C2H4Br2O
Synonyms:
  • Dibrom ether
  • Bromo(bromomethoxy)methane
  • Methane, oxybis[bromo- (9CI)
  • Dibromomethyl ether
  • Oxybis(bromomethane)
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
  • Bis(bromomethyl) ether

    CAS:
    Formula:C2H4Br2O
    Purity:96%
    Color and Shape:Liquid
    Molecular weight:203.8606

    Ref: IN-DA00DP4F

    1g
    359.00€
    5g
    To inquire
    10g
    To inquire
    100mg
    167.00€
    250mg
    163.00€
  • Bromo(bromomethoxy)methane

    CAS:
    Purity:96%(stabilized with Cu)
    Color and Shape:Liquid
    Molecular weight:203.8609924

    Ref: 10-F626915

    1g
    525.00€
    5g
    1,882.00€
    10g
    3,556.00€
    100mg
    201.00€
    250mg
    256.00€
  • Bromo(bromomethoxy)methane

    Controlled Product
    CAS:
    <p>Bromo(bromomethoxy)methane is a heterocyclic compound that is also known as bromobemidone. It is used in the treatment of cancer and bowel disease. Bromobemidone has been shown to inhibit tumor growth by inducing apoptotic cell death, which may be due to its ability to activate c-b2 receptor, a protein found on the surface of T cells. Bromobemidone also has an inhibitory effect on inflammatory bowel disease and diabetic neuropathy. This drug can act as an adenosine receptor antagonist, which means that it blocks signals from the receptors for adenosine, a chemical involved in regulating blood flow and other processes in the body.</p>
    Formula:C2H4Br2O
    Purity:Min. 95%
    Molecular weight:203.86 g/mol

    Ref: 3D-EAA49729

    1g
    1,008.00€